rs864622744
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PP3_ModerateBS2
The NM_001136472.2(LITAF):c.479G>A(p.Arg160His) variant causes a missense change. The variant allele was found at a frequency of 0.0000093 in 1,612,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001136472.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152058Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249474Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134882
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460306Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726358
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74260
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -
- -
not specified Uncertain:1
Variant summary: LITAF c.479G>A (p.Arg160His) results in a non-conservative amino acid change located in the LPS-induced tumour necrosis factor alpha factor (IPR006629) of the encoded protein sequence. Three of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 249474 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.479G>A has been reported in the literature in at least 1 individual affected with clinical features of Charcot-Marie-Tooth disease type 1C (example, Peddareddygari_2023). These report(s) do not provide unequivocal conclusions about association of the variant with Charcot-Marie-Tooth disease type 1C. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 37868241). ClinVar contains an entry for this variant (Variation ID: 221090). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Charcot-Marie-Tooth disease Uncertain:1
- -
Charcot-Marie-Tooth disease type 1C Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 160 of the LITAF protein (p.Arg160His). This variant is present in population databases (no rsID available, gnomAD 0.006%). This missense change has been observed in individuals with clinical features of LITAF-related conditions (PMID: 37868241; internal data). This missense change has been observed in at least one individual who was not affected with LITAF-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 221090). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Arg160 amino acid residue in LITAF. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28211240, 32376792; internal data). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The p.R160H variant (also known as c.479G>A), located in coding exon 3 of the LITAF gene, results from a G to A substitution at nucleotide position 479. The arginine at codon 160 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
LITAF-related disorder Uncertain:1
The LITAF c.479G>A variant is predicted to result in the amino acid substitution p.Arg160His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0057% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at